Interested in discovering how you can protect your study endpoints during COVID-19 and beyond? Click here to learn how WCG's integrated Endpoint Protection Solution can be leveraged for your clinical trial's needs.
Most Recent Flipbooks
WCG Analgesic Solutions found that patients could better report their pain intensity and discriminate between active drug and placebo using accurate pain reporting training.
ThreeWire was able to quickly review charts at the 48 sites, leading to 121 consents and 69 enrolled subjects. These efforts contributed 34.5% of all enrollments.